Skip to main content
. 2015 Jun 17;6(3):289–302. doi: 10.1007/s13300-015-0117-z

Fig. 1.

Fig. 1

Study flow diagram. ALT alanine aminotransferase, CANA canagliflozin, CANVAS CANagliflozin cardioVascular Assessment Study, eGFR estimated glomerular filtration rate, LOCF last observation carried forward, mITT modified intent-to-treat, PBO placebo, SU sulfonylurea